RedHill Biopharma Ltd. (RDHL)

NASDAQ: RDHL · Real-Time Price · USD

2.20

0.03 (1.38%)

At close: Apr 29, 2025, 11:05 AM

RedHill Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Cash & Equivalents	4.62M	7.28M	7M	17.57M	19.97M	15.2M	26.99M	28.85M	29.47M	23.25M	51.82M	75.97M	29.3M	26.2M	22.27M	81.61M	29.02M	11.63M	8.99M	23.01M	29M	18.68M	5.56M	7.56M	16.45M	18.66M	15.32M	29.62M	53.79M	6.77M	3.42M	12.03M
Short-Term Investments	n/a	n/a	18K	15K	15K	15K	15K	17K	8.53M	12.03M	3.52M	16K	498K	8.59M	10.66M	13.32M	18.85M	14.02M	25.87M	22.52M	24.18M	24.34M	22.34M	28.79M	29.75M	20.77M	35.75M	30.96M	12.37M	33.73M	44.31M	41.25M
Long-Term Investments	n/a	n/a	n/a	146K	150K	148K	150K	16.17M	16.17M	16.16M	16.16M	16.16M	16.16M	n/a	n/a	n/a	152K	151K	147K	145K	140K	145K	144K	150K	152K	149K	150K	145K	137K	140K	137K	140K
Other Long-Term Assets	148K	143K	143.92K	146K	150K	148K	150K	16.16M	16.17M	16.16M	16.16M	16.16M	16.16M	16.15M	20.15M	21.33M	152K	-9.44M	4M	3.04M	-5.62M	-5.61M	-5.63M	-5.66M	152K	149K	150K	145K	137K	140K	137K	140K
Receivables	3.57M	3.88M	5.95M	12.02M	37.88M	39.3M	33.76M	25.93M	32.52M	30.04M	30.1M	23.31M	29.29M	12.42M	18.57M	1.72M	1.64M	853K	963K	1.42M	1.4M	1.92M	1.8M	1.81M	2.26M	1.4M	778K	n/a	492K	n/a	n/a	n/a
Inventory	3.65M	3.8M	4.94M	5.86M	11.01M	12.58M	11.72M	14.27M	14.81M	13.12M	8.76M	9.27M	6.53M	5.1M	4.75M	2.77M	1.88M	1.96M	1.83M	1.29M	769K	469K	690K	560K	653K	221K	610K	n/a	1.11M	n/a	n/a	n/a
Other Current Assets	n/a	739K	12.19M	11.05M	16M	16M	16M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	11.91M	15.7M	27.05M	46.52M	85.9M	83.1M	91.27M	72.58M	89.15M	83.11M	98.49M	112.66M	70.5M	56.95M	61.13M	101.03M	53.21M	30.8M	39.97M	49.48M	56.79M	47.77M	32.22M	40.74M	51.68M	43.81M	55.55M	63.26M	67.81M	42.53M	49.91M	55.21M
Property-Plant & Equipment	437K	616K	2.25M	6.57M	7.19M	6.8M	7.81M	8.26M	4.22M	4.67M	4.8M	5.25M	5.7M	5.92M	5.57M	5.27M	3.81M	3.97M	4.25M	3.19M	163K	181K	200K	221K	230K	250K	235K	151K	165K	147K	148K	143K
Goodwill & Intangibles	5.55M	5.56M	5.59M	5.6M	65.63M	67.14M	68.74M	70.04M	71.64M	82.39M	84.22M	86.05M	87.88M	89.96M	79.52M	15.85M	16.93M	5.32M	5.32M	5.32M	5.32M	5.29M	5.29M	5.29M	5.29M	6.08M	6.05M	6.05M	6.09M	6.06M	6.06M	6.06M
Total Long-Term Assets	6.13M	6.32M	7.99M	12.32M	72.97M	74.09M	76.7M	94.47M	92.04M	103.22M	105.18M	107.47M	109.75M	112.03M	105.24M	42.45M	20.89M	9.44M	9.72M	8.65M	5.62M	5.61M	5.63M	5.66M	5.67M	6.48M	6.43M	6.35M	6.4M	6.35M	6.34M	6.34M
Total Assets	18.04M	22.02M	35.04M	58.83M	158.87M	157.19M	167.97M	167.05M	181.19M	186.34M	203.67M	220.12M	180.24M	168.98M	166.37M	143.48M	74.1M	40.24M	49.7M	58.13M	62.41M	53.38M	37.85M	46.39M	57.34M	50.3M	61.98M	69.61M	74.21M	48.88M	56.26M	61.55M
Account Payables	7.86M	1.91M	3.11M	4.37M	4.23M	4.78M	4.37M	5.71M	11.66M	15.24M	13.31M	6.54M	11.55M	6.57M	5.31M	3.19M	4.18M	4.79M	4.74M	4.41M	3.32M	3.87M	4.02M	2.72M	4.8M	1.88M	1.15M	1.78M	60K	5.29M	4.75M	3.58M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	37.31M	36.32M	38.08M	35.78M	19.51M	-1.55M	-1.37M	-1.23M	5.49M	-943K	7.62M	6.25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	115.22M	113.86M	85.51M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	11.31M	14.99M	16.38M	43.09M	49.65M	41.78M	39.22M	31.39M	34.37M	28.36M	26.1M	22.68M	23.45M	n/a	n/a	n/a	2.6M	n/a	n/a	n/a	1.46M	n/a	n/a	n/a	1.06M	n/a	n/a	2.01M	393K	2M	2M	n/a
Total Current Liabilities	22.22M	21.23M	28.19M	48.44M	197.45M	193.53M	166.41M	73.9M	81.47M	81.66M	79.17M	66.63M	73.23M	31.65M	35.87M	17.32M	10.62M	13.88M	14.05M	12.09M	10.38M	11M	9.88M	9.71M	11.83M	12.03M	10.56M	5.79M	5.36M	7.29M	6.75M	5.58M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	86.4M	83.62M	83.52M	83.16M	82.52M	81.39M	80.27M	79.19M	78.17M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	500K	540K	2.38M	2.38M	3.37M	3.68M	6.82M	4.81M	4.65M	6.76M	8.79M	14.54M	7.95M	24.24M	12.68M	500K	500K	508K	513K	1.82M	844K	2.54M	2.06M	398K	448K	4.31M	2.62M	4.87M	6.16M	1.11M	522K	1.04M
Total Long-Term Liabilities	503K	730K	3.38M	8.39M	9.82M	9.69M	13.49M	98.39M	90.84M	93.13M	94.92M	100.45M	93.14M	108.58M	95.91M	82.51M	3.48M	3.51M	3.74M	4.17M	844K	2.54M	2.06M	398K	448K	4.31M	2.62M	4.87M	6.16M	1.11M	522K	1.04M
Total Liabilities	22.73M	21.96M	31.57M	56.83M	207.27M	203.22M	179.91M	172.29M	172.31M	174.79M	174.09M	167.08M	166.38M	140.24M	131.78M	99.83M	14.1M	17.39M	17.79M	16.26M	11.22M	13.53M	11.94M	10.1M	12.28M	16.34M	13.18M	10.66M	11.51M	8.39M	7.28M	6.62M
Total Debt	356K	558K	2.28M	6.99M	122.69M	120.83M	93.65M	95.01M	87.81M	88.11M	87.83M	87.55M	86.9M	85.89M	84.6M	83.24M	3.81M	3.95M	4.07M	3.07M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	35.04M	34.78M	4.62M	2.85M	2.83M	1.83M	1.83M	1.51M	1.5M	1.32M	1.31M	1.31M	1.05M	1.02M	986K	962K	962K	767K	767K	767K	767K	690K	577K	577K	575K	459K	458K	455K	441K	344K	344K	343K
Retained Earnings	-414.8M	-410.06M	-382.01M	-383.48M	-433.86M	-431.27M	-397.18M	-382.7M	-367.87M	-345.37M	-326.17M	-302.32M	-280.33M	-257.08M	-240.14M	-224.72M	-208.36M	-197.42M	-188.37M	-178.4M	-169.09M	-162.07M	-152.46M	-142.07M	-132.94M	-123.11M	-108.24M	-97.92M	-89.64M	-81.65M	-73.15M	-67.09M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-341K	n/a	n/a	n/a	-251K	n/a	n/a	n/a	-170K	n/a	n/a	n/a
Shareholders Equity	-4.68M	61K	3.47M	2M	-48.4M	-46.03M	-11.94M	-5.24M	8.88M	11.55M	29.58M	53.04M	13.86M	28.75M	34.59M	43.65M	60M	22.85M	31.9M	41.88M	51.19M	39.84M	25.91M	36.29M	45.06M	33.96M	48.8M	58.95M	62.7M	40.48M	48.98M	54.94M
Total Investments	n/a	n/a	18K	15K	15K	15K	15K	17K	8.53M	12.03M	3.52M	16K	498K	8.59M	10.66M	13.32M	19M	14.17M	26.02M	22.66M	24.32M	24.49M	22.48M	28.94M	29.9M	20.92M	35.9M	31.11M	12.51M	33.87M	44.45M	41.39M

Advertisement

RedHill Biopharma Ltd. (RDHL)

RedHill Biopharma Balance Sheet Statement